These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19395626)

  • 1. Interpretation of the glaucoma "landmark studies".
    Wishart PK
    Br J Ophthalmol; 2009 May; 93(5):561-2. PubMed ID: 19395626
    [No Abstract]   [Full Text] [Related]  

  • 2. The logic behind target intraocular pressure.
    Coleman AL; Caprioli J
    Am J Ophthalmol; 2009 Mar; 147(3):379-80. PubMed ID: 19217951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ocular hypertension--follow up or treatment?].
    Stefan C; Dumitrica DM; Dragomir L; Cristea I; Sapundgieva A
    Oftalmologia; 2009; 53(2):23-5. PubMed ID: 19697835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ocular hypertension treatment study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?
    Robin AL; Frick KD; Katz J; Budenz D; Tielsch JM
    Arch Ophthalmol; 2004 Mar; 122(3):376-8. PubMed ID: 15006854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy for glaucoma].
    Määttä M; Puska P
    Duodecim; 2009; 125(15):1657-63. PubMed ID: 19769182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When and how we start the treatment in patients with ocular hypertension or in glaucoma suspects?].
    Stefan C; Ene L; Coravu CO
    Oftalmologia; 2014; 58(1):15-7. PubMed ID: 25145118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.
    Lusthaus JA; Goldberg I
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1201-8. PubMed ID: 27548834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.
    Olthoff CM; Schouten JS; van de Borne BW; Webers CA
    Ophthalmology; 2005 Jun; 112(6):953-61. PubMed ID: 15885795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of raised intraocular pressure and prevention of glaucoma.
    Wormald R
    BMJ; 2003 Apr; 326(7392):723-4. PubMed ID: 12676823
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular hypotensive medications for the treatment of glaucoma.
    Lee DA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Approaches to reduction of intraocular pressure by 30% in patients with glaucoma (review of literature)].
    Kuroedov AV; Brezhnev AIu; Aleksandrov AS
    Voen Med Zh; 2009 Jun; 330(6):40-6. PubMed ID: 19791687
    [No Abstract]   [Full Text] [Related]  

  • 12. Are all glaucoma drugs equally effective?
    Schmetterer L
    Acta Ophthalmol; 2010 Aug; 88(5):503. PubMed ID: 20653570
    [No Abstract]   [Full Text] [Related]  

  • 13. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
    Bean GW; Camras CB
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 10-year incidence of glaucoma among patients with treated and untreated ocular hypertension.
    Gordon MO; Gao F; Beiser JA; Miller JP; Kass MA
    Arch Ophthalmol; 2011 Dec; 129(12):1630-1. PubMed ID: 22159688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the OHTS results into clinical practice.
    Cioffi GA; Liebmann JM
    J Glaucoma; 2002 Oct; 11(5):375-7. PubMed ID: 12362074
    [No Abstract]   [Full Text] [Related]  

  • 17. Delaying glaucoma.
    Health News; 2002 Dec; 8(12):8. PubMed ID: 12523272
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
    Pintor J
    Curr Opin Investig Drugs; 2005 Jan; 6(1):76-80. PubMed ID: 15675606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of Cosopt in glaucoma treatment].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(4):15-25. PubMed ID: 19354158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.
    Harrison BA; Whitlock NA; Voronkov MV; Almstead ZY; Gu KJ; Mabon R; Gardyan M; Hamman BD; Allen J; Gopinathan S; McKnight B; Crist M; Zhang Y; Liu Y; Courtney LF; Key B; Zhou J; Patel N; Yates PW; Liu Q; Wilson AG; Kimball SD; Crosson CE; Rice DS; Rawlins DB
    J Med Chem; 2009 Nov; 52(21):6515-8. PubMed ID: 19831390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.